Sign Up Today and Learn More About Atomwise Stock
Invest in or calculate the value of your shares in Atomwise or other pre-IPO companies through EquityZen's platform.
Atomwise Stock
Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.
About Atomwise Stock
Founded
2012
Headquarters
San Francisco, CA, US
Total Funding
6.6M
Industries
The Atomwise Advantage Using computers to discover medicines is a great idea, but execution is everything. With lives and budgets on the line, accuracy matters. Previous attempts haven't always met expectations. The techniques of the day were limited by the knowledge and computers available. Today, things are different. They have invented cutting-edge machine learning algorithms that are built specifically for the world's most powerful computers. They use one of the world's top supercomputers to analyze databases 1000 times larger than those used in the past. This lets us deliver what many others can't: precise and reliable medicinal predictions.
Atomwise Press Mentions
Stay in the know about the latest news on Atomwise
Five AI drug discovery companies you should know about
labiotech • Jun 26, 2024
Flipping the Script: Atomwise AI Platform Presents an Alternative to High Throughput Screening
genengnews • May 19, 2024
Characterization of interactions between compounds and polymers using pose …
patents • Apr 14, 2024
Systems and method for query-based random access into virtual chemical …
patents • Apr 14, 2024
Anat inhibitors and methods of use thereof
patents • Apr 14, 2024
Atomwise Management
Leadership team at Atomwise
CEO
Abraham Heifets
CTO
Dr. Izhar Wallach
Join now and verify your accreditation status to gain access to:
- Atomwise current valuation
- Atomwise stock price
- Available deals in Atomwise and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Atomwise stock?
Accredited investors can buy pre-IPO stock in companies like Atomwise through EquityZen funds. These investments are made available by existing Atomwise shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Atomwise stock?
Shareholders can sell their Atomwise stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
